Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.5 (
neuropathy target esterase
)
1,070
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
As a
phospholipase B
,
neuropathy target esterase
(
NTE
) is responsible for the conversion of phosphatidylcholine (PC) to glycerophosphocholine (GPC). We examined the role of cAMP in the regulation of
NTE
in mammalian cells. Endogenous
NTE
activity was increased by cAMP-elevating chemicals, including dibutyryl cAMP, forskolin and forskolin plus 1-isobutyl-3-methylxanthine (IBMX), but decreased by the
adenyl cyclase
inhibitor SQ22536 which can reduce intracellular cAMP levels. Exogenous GFP-tagged
NTE
activity was not affected by changes in intracellular cAMP.
NTE
protein levels were up-regulated by the cAMP-elevating reagents and down-regulated by the inhibitor. The effect of the
adenyl cyclase
activator forskolin on
NTE
protein and mRNA levels was blocked by pretreatment with the protein kinase A (PKA) activity inhibitor H89. In addition, we found that changes in GPC, but not PC, levels were correlated with cAMP induced changes in
NTE
activity. These results are the first evidence that cAMP/PKA signals regulate
NTE
expression and GPC content in mammalian cells.
...
PMID:Regulation of neuropathy target esterase by the cAMP/protein kinase A signal. 2038 Aug 79